Breast cancer

What endocrine adjuvant treatment is recommended in high-risk premenopausal breast cancer
patients?

Ovarian suppression plus exemestane

High risk disease defined as requiring chemotherapy, large tumor size, lymphovascular invasion, high-
grade, high recurrence risk score, age younger than 35

SOFT and TEXT trials

en_USEnglish